Allergan in AD deal after calling off Pfizer merger

Less than a day after Allergan plc (NYSE:AGN) and Pfizer Inc. (NYSE:PFE) called off their proposed merger, Allergan obtained rights to a portfolio of muscarinic agonists from the Heptares Therapeutics Ltd. subsidiary of Sosei

Read the full 349 word article

User Sign In